These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23737217)

  • 1. Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences.
    Litwin M; Michałkiewicz J; Gackowska L
    Curr Hypertens Rep; 2013 Aug; 15(4):331-9. PubMed ID: 23737217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities.
    Litwin M; Feber J; Niemirska A; Michałkiewicz J
    Pediatr Nephrol; 2016 Feb; 31(2):185-94. PubMed ID: 25724169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine].
    Ostroumova OD; Zykova AA
    Kardiologiia; 2016 Oct; 56(10):72-79. PubMed ID: 28290898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic neural activity in hypertension and related diseases.
    Grassi G
    Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol.
    Marketou M; Gupta Y; Jain S; Vardas P
    Curr Hypertens Rep; 2017 Mar; 19(3):22. PubMed ID: 28283926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic mechanisms, organ damage, and antihypertensive treatment.
    Grassi G; Seravalle G; Dell'Oro R; Mancia G
    Curr Hypertens Rep; 2011 Aug; 13(4):303-8. PubMed ID: 21451943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
    Grassi G
    Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathomodulatory Effects of Antihypertensive Drug Treatment.
    Grassi G
    Am J Hypertens; 2016 Jun; 29(6):665-75. PubMed ID: 26888777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic considerations in hypertension.
    Tuck ML
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):355S-365S. PubMed ID: 2078323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growing epidemic of hypertension among children and adolescents: a challenging road ahead.
    Assadi F
    Pediatr Cardiol; 2012 Oct; 33(7):1013-20. PubMed ID: 22565200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Hypertension Induced Target Organ Damage in Children and Adolescents.
    Chrysaidou K; Stabouli S
    Curr Pharm Des; 2018; 24(37):4378-4384. PubMed ID: 30479207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.
    Sladowska-Kozłowska J; Litwin M; Niemirska A; Płudowski P; Wierzbicka A; Skorupa E; Wawer ZT; Janas R
    Pediatr Nephrol; 2012 Oct; 27(10):1943-51. PubMed ID: 22660895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.
    Makaryus AN; Akhrass P; McFarlane SI
    Curr Diab Rep; 2009 Jun; 9(3):229-37. PubMed ID: 19490825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.